You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 206 No. 10, December 2, 1968 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cytogenetic Effects of LSD 25 Therapy in Man

David A. Hungerford, PhD; Kenneth M. Taylor, PhD; Charles Shagass, MD; Gundula U. LaBadie; Gloria B. Balaban, MA; Gillian R. Paton

JAMA. 1968;206(10):2287-2291.


Abstract

Chromosomes have been studied in leukocytes cultured from patients undergoing experimental therapy with lysergic acid diethylamide (LSD 25). Aberration frequencies prior to therapy were established for three of the four patients; these were comparable to frequencies in control subjects. Following each of three doses given intravenously (usually 200µg per dose), each patient's chromosomes were reexamined. Some increase in aberration frequency was observed, along with the appearance of some types of aberration not present before treatment. However, a return to control levels occurred in follow-up samples taken one to six months after the final dose was administered. We feel therefore that continued experimental therapy is not strongly contraindicated. On the other hand, these results can not be construed to minimize the possible cytogenetic hazards suggested by other studies concerned primarily with drug abuse.



Author Affiliations

From the Institute for Cancer Research, and Eastern Pennsylvania Psychiatric Institute, Philadelphia. Dr. Taylor is now at San Diego (Calif) State College, and Gillian Paton is now at the Medical Research Council, Mill Hill, London.


Footnotes

Reprint requests to 7701 Burholme Ave, Philadephia 19111 (Dr. Hungerford).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Peyote on Human Chromosomes: Cytogenetic Study of the Huichol Indians of Northern Mexico
Dorrance et al.
JAMA 1975;234:299-302.
ABSTRACT  

Chromosomal Analyses of Bone Marrow and Peripheral Blood in Subjects With a History of Illicit Drug Use
Amarose and Schuster
Arch Gen Psychiatry 1971;25:181-186.
ABSTRACT  

LSD and Genetic Damage
Dishotsky et al.
Science 1971;172:431-440.
ABSTRACT  

Chromosomal Aberrations in Users of Psychoactive Drugs
Gilmour et al.
Arch Gen Psychiatry 1971;24:268-272.
ABSTRACT  

Effect of LSD on Human Pregnancy
McGlothlin et al.
JAMA 1970;212:1483-1487.
ABSTRACT  

In Vivo Effects of Illicit Hallucinogens on Human Lymphocyte Chromosomes
Dorrance et al.
JAMA 1970;212:1488-1491.
ABSTRACT  

LSD and Chromosomes: A Controlled Experiment
Tjio et al.
JAMA 1969;210:849-856.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.